CALCA and Hepatosplenomegaly: These data indicate a link between oxLDL, 7-KC, G-CSF production, and splenomegaly and suggest E06 as a potential therapy for the peripheral symptoms of NPC1 disease, mainly with regard to the hepatosplenomegaly.